Sigma Planning Corp Matinas Bio Pharma Holdings, Inc. Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$0.67 - $0.96 $8,442 - $12,096	-12,600 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$0.52 - $0.92 $329 - $583	634 Added 5.3%	12,600 $10,000
Q1 2020 May 01, 2020	SELL	$0.6 - $2.31 $510 - $1,965	-851 Reduced 6.64%	11,966 $7,000
Q4 2019 Feb 03, 2020	BUY	$0.63 - $2.27 $8,074 - $29,094	12,817 New	12,817 $29,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.